Previous 10 | Next 10 |
Gainers: Inspire Medical Systems (INSP) +24%, GW Pharmaceuticals (GWPH) +15%, Aptevo Therapeutics (APVO) +14%, Galera Therapeutics (GRTX) +11%, DBV Technologies (DBVT) +10%.Losers: Esperion Therapeutics (ESPR) -15%, Aurinia Pharmaceuticals (AUPH)...
Apartment Investment and Management (AIV) -23%.SolarEdge Technologies (SEDG) -18% on Q3 earnings release.Pacific Biosciences of California (PACB) -10% on Q3 earnings release.Aurinia Pharmaceuticals (AUPH) -9% on suspending voclosporin program as Phase 2/3 study f...
Image source: The Motley Fool. Esperion Therapeutics Inc (NASDAQ: ESPR) Q3 2020 Earnings Call Nov 2, 2020 , 4:30 p.m. ET Operator Continue reading For further details see: Esperion Therapeutics Inc (ESPR) Q3 2020 Earnings Call Transcript ...
Esperion Therapeutics, Inc. (ESPR) Q3 2020 Earnings Conference Call November 02, 2020 4:30 PM ET Company Participants Ben Church - Investor Relations and Corporate Communications Tim Mayleben - President & Chief Executive Officer Mark Glickman - Chief Commercial Officer Rick Bartram - Chi...
– Quarter-over-quarter Script Growth Exceeded 500 Percent for NEXLETOL ® (bempedoic acid) and NEXLIZET ® (bempedoic acid and ezetimibe) tablets – – U.S. Product Revenue Increased Five-fold During the Third Quarter – ...
Esperion Therapeutics (NASDAQ:ESPR) is scheduled to announce Q3 earnings results on Monday, November 2nd, after market close.The consensus EPS Estimate is -$3.57 (-41.7% Y/Y) and the consensus Revenue Estimate is $4.04M (+312.2% Y/Y).Over the last 2 years, ESPR has beaten EPS estimates 38% of...
ANN ARBOR, Mich., Oct. 27, 2020 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced that members of Esperion management will participate in three upcoming virtual conferences during the month of November. A live audio webcast of the virtual conference presentations can be acc...
ANN ARBOR, Mich., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced it will report third quarter 2020 financial results after the close of the U.S. financial markets on Monday, November 2, 2020. Following the release, company management will host a webcast and...
ANN ARBOR, Mich., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced results of pooled data from two of the company’s Phase 3 trials were presented at the virtual 88 th Annual Congress of the European Atherosclerosis Society (EAS 2020). Both trials demonstr...
ANN ARBOR, Mich., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced the launch of “Break the Cycle with NEXLETOL”, a national direct-to-consumer (DTC) campaign aimed at broadening awareness of NEXLETOL® (bempedoic acid) Tablets and the never-endin...
News, Short Squeeze, Breakout and More Instantly...
Esperion Therapeutics Inc. Company Name:
ESPR Stock Symbol:
NASDAQ Market:
Esperion Therapeutics Inc. Website:
ANN ARBOR, Mich., July 25, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report second quarter 2024 financial results before the market opens on Monday, August 12, 2024. Following the release, management will host a webcast at 8:00 a.m. ET to discuss these financi...
ANN ARBOR, Mich., July 24, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the BTIG Biotech Conference on Monday, August 5, 2024, at 4 p.m. ET. Esperion Therapeutics At Esperion, we discover, develop, and commercialize innovat...
– Targeted Campaign Reaches Patients at Risk for Heart Attack or Heart Procedures Because of High LDL Cholesterol (LDL-C) – – Animated Characters Are a Visual Representation of An Unseen Risk “Lurking” In Patients’ Artery Walls &...